Electra Therapeutics

Drug DiscoveryWebsite
Current Valuation
$479.0M
As of October 15, 2025
Total Funding Raised
$301.0M
Across 2 rounds
Last Round
Later Stage VC

$183.0M

Last Funding
Oct 2025

Funding date

Capital Efficiency
1.59x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
October 22, 2025Later Stage VC (Series C)$183.0MN/A-
February 16, 2022Early Stage VC (Series B)$84.0MN/A-
Valuation Analysis

Current Valuation Metrics

Electra Therapeutics is currently valued at $479.0M as of October 15, 2025. The company has raised a total of $301.0M in funding across 2 funding rounds.

Capital Efficiency

With a capital efficiency ratio of 1.59x, Electra Therapeutics has achieved a valuation that is 1.59 times the total capital raised.

Track Electra Therapeutics Valuation Updates

Get notified when Electra Therapeutics raises new funding or valuation changes

View 5 companies free

Create a free account to unlock Electra Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Electra Therapeutics Worth in 2026?

Electra Therapeutics is a leading private company in the Drug Discovery sector. Track Electra Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Electra Therapeutics Valuation is Determined

Private company valuations like Electra Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.